cAMPfield Therapeutics

formerly cAMPfield

cAMPfield Therapeutics is a biotech company in San Diego, United States, founded in 2026. It has raised $180.0M across 1 round, most recently a $180.0M Series A in June 2026.

Redefining the Treatment of Inflammatory Diseases

Employees
1–10
Founded
2026
Business Model
Other
Total Funding
$180.0M
Last Round
$180.0M Series AJun 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 8 investors for this company. The full record is or through the API.

About

cAMPfield Therapeutics is a clinical-stage biopharmaceutical company headquartered in San Diego, developing well-tolerated and highly effective oral medicines for immune-mediated inflammatory diseases, including inflammatory bowel disease (IBD). Its lead candidate, prifemilast, is a once-daily oral PDE4B-selective inhibitor licensed from Newsoara Biopharma that has been dosed in over 700 clinical trial participants and demonstrated efficacy in a completed Phase 3 trial for plaque psoriasis. The company was founded by Mountainfield Venture Partners alongside executives who led development of Entyvio, Humira, Otezla, and Zeposia, and is now advancing prifemilast into global Phase 2b trials for ulcerative colitis and Phase 2 trials for Crohn's disease.

Summary

It lists 1–10 employees. It has raised $180.0M in total across 1 round, most recently a $180.0M Series A round in Jun 2026. Investors include Frazier Life Sciences, Deep Track Capital and Forbion Capital Partners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AJun 2026
$180.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

cAMPfield Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/campfield-therapeutics"><img src="https://indexed.vc/api/badge/company/campfield-therapeutics" alt="cAMPfield Therapeutics on Indexed.vc" width="260" height="76" /></a>